Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Surmodics (SRDX)
NASDAQ:SRDX
Holding SRDX?
Track your performance easily
SRDX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$25.17 - $42.44
Previous Close$38.49
Volume62.28K
Average Volume (3M)380.86K
Market Cap
$549.14M
Enterprise Value$540.48M
Total Cash (Recent Filing)$38.17M
Total Debt (Recent Filing)$29.52M
Price to Earnings (P/E)―
Beta1.14
Next Earnings
Nov 06, 2024EPS Estimate
-$0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding14,267,000
10 Day Avg. Volume275,205
30 Day Avg. Volume380,861
Standard Deviation0.16
R-Squared0.16
Alpha-0.00771
Financial Highlights & Ratios
Price to Book (P/B)4.65
Price to Sales (P/S)4.55
Price to Cash Flow (P/CF)-67.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.47
Enterprise Value/Gross Profit8.86
Enterprise Value/Ebitda90.50
Forecast
1Y Price Target
$43.00Price Target Upside11.72% Upside
Rating ConsensusHold
Number of Analyst Covering3
SurModics News
PremiumCompany Announcements
Ronald B. Kalich Resigns from SurModics Board Amicably
Bulls Say, Bears Say
Bulls Say
Cash FlowCash flow from operations in the third quarter was -$2.0 million, better than the estimated -$3.4 million.
Financial PerformanceSRDX’s F3Q24 revenue, adjusted EBITDA, and EPS beat consensus.
Royalty And Licensing RevenueSurmodics generated $10.5 million in royalty and licensing revenue in the quarter, solidly exceeding the $9.4 million estimate.
Bears Say
Financial GuidanceManagement chose to forego a conference call and suspended its previously issued financial guidance for FY/24.
MergerSurmodics and GTCR received a request for additional information and documentary materials from the United States Federal Trade Commission in connection with the merger.
Revenue GrowthSRDX's revenue growth, excluding the ABT milestone payment, slowed to 9% in F3Q24 from 18% in F2Q24.
---
Ownership Overview
434.80% Insiders
1776.18% Mutual Funds
4507.73% Other Institutional Investors
2034.96% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SRDX FAQ
What was Surmodics’s price range in the past 12 months?
Surmodics lowest stock price was $25.17 and its highest was $42.44 in the past 12 months.
What is Surmodics’s market cap?
Currently, no data Available
When is Surmodics’s upcoming earnings report date?
Surmodics’s upcoming earnings report date is Nov 06, 2024 which is in 19 days.
How were Surmodics’s earnings last quarter?
Surmodics released its earnings results on Jul 31, 2024. The company reported -$0.27 earnings per share for the quarter, beating the consensus estimate of -$0.338 by $0.068.
Is Surmodics overvalued?
According to Wall Street analysts Surmodics’s price is currently Undervalued.
Does Surmodics pay dividends?
Surmodics does not currently pay dividends.
What is Surmodics’s EPS estimate?
Surmodics’s EPS estimate is -$0.29.
How many shares outstanding does Surmodics have?
Surmodics has 14,267,000 shares outstanding.
What happened to Surmodics’s price movement after its last earnings report?
Surmodics reported an EPS of -$0.27 in its last earnings report, beating expectations of -$0.338. Following the earnings report the stock price went down -0.241%.
Which hedge fund is a major shareholder of Surmodics?
Among the largest hedge funds holding Surmodics’s share is Gamco Investors, Inc. ET AL. It holds Surmodics’s shares valued at 7M.
---
SurModics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$43.00 (11.72% Upside)
$43.00 (11.72% Upside)
Blogger Sentiment
Bullish
SRDX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 240.8K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
23.76%
12-Months-Change
Fundamentals
Return on Equity
-1.21%
Trailing 12-Months
Asset Growth
-6.08%
Trailing 12-Months
Company Description
Surmodics
SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through the Medical Device and In Vitro Diagnostics segments. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.
---
SRDX Earnings Call
Q2 2024
0:00 / 0:00
---
SRDX Stock 12 Month Forecast
Average Price Target
$43.00
▲(11.72% Upside)
Technical Analysis
---